Our Latest News

Open letters 10/02/2012

Letter to Michel Kazatchkine, Executive Director of the Global Fund to Fight Aids, Tuberculosis, and Malaria

A letter has been sent to Michel Kazatchkine, Executive Director of the Global Fund to Fight Aids, Tuberculosis, and Malaria, to thank him for his personal contribution to the positive impact that programs funded by the Global Fund have had on millions of lives in the region of Europe and Central Asia.

Projects 02/02/2012

The European Patients' Academy on Therapeutic Innovation (EUPATI)

EUPATI-Logo-4c

European Patients' Academy on Therapeutic Innovation (EUPATI). launched on 1st February 2012.

Upcoming events 23/01/2012

Risk Talk on HIV - insuring the uninsurable - Join the live webcast for the Risk Talk today at 18:00 CET

"We are going to win this fight." President Barack Obama declared on 1 December 2011, World AIDS Day. The prospect of "an Aids-free generation" was unimaginable just a short while ago.

Correlation Network II 12/01/2012

Correlation Network II

Report of the final Conference of Correlation Network II "Getting out of the margins – changing realities and making the difference"

12-14 December, Ljubljana, Slovenia

Correlation Network II 12/01/2012

New Policy Recommendations for Vulnerable Populations

The prevalence of HIV/AIDS and other blood-borne infectious diseases is known to be high in vulnerable populations. Concerned about a resurgent HIV epidemic concentrated among key populations in the European Union (EU) and European Free Trade Area countries (EFTA)

Vacancies 12/01/2012

Volunteer - European Voluntary Service (EVS)

The EATG is looking for a volunteer to support us with our communication work towards people living with HIV/AIDS and other stakeholders. The volunteer would be involved in projects to raise awareness about HIV in Europe, mainly among young communities.

Upcoming events 09/01/2012

HIV 30 years on - the impact on society and the insurance industry

26 - 27 January 2012, event organised by the Swiss Re Insurance Company Ltd. and Aids-Hilfe Schweiz

About us 15/12/2011

Contact us

Our office will be closed from December 24th until January 8th 2011. We wish you Happy Holidays and a Happy New Year!

Global HIV News

HIV & STIs 10/02/2012

Routine screening for STIs urged

Screening and treating STIs improves personal health, stops STIs from spreading and may help reduce the transmission of HIV.

Treatment 10/02/2012

Cotrimoxazole prophylaxis reduces death rate by almost 60% in adults taking ART in low and middle-income countries

Further research is needed to determine the optimum length of time for cotrimoxazole treatment in HIV-infected adults on ART.

Access to treatment 10/02/2012

Novartis, Big Pharma, and their US and EU surrogates throw a triple punch at Indian generics

For Big Pharma multinationals like Novartis, patent and data monopolies are the geese that lay golden eggs.

Access to treatment 10/02/2012

EU-India summit kicks off amidst warnings of impact on medicines access

Intellectual property provisions in a bilateral free trade agreement under negotiation will stifle critical generic medicines production in India, putting thousands of poor patients at risk worldwide.

Tuberculosis & Malaria 10/02/2012

Examining malaria data methodologies

"Given the 1.2 billion dollars by donors to malaria in 2010, is it unreasonable to demand to know with more certainty, how many people are dying from malaria?"

World Policy 10/02/2012

Funding squeeze, apathy risk another half century of AIDS - UN expert

Global apathy and the financial crisis mean it might take another 50 years to stop the AIDS epidemic.

Treatment 10/02/2012

FDA panel: Qutenza pain patch for neuropathy not ready for approval

A U.S. Food and Drug Administration advisory committee voted unanimously against recommending the approval of a novel patch applied to the soles of the feet to remedy pain associated with neuropathy in people living with HIV.

HIV & STIs 10/02/2012

Antibiotics losing battle against gonorrhea

The last line of therapeutic defense against gonorrhea is losing its strength.

Print